01 7Methycobal
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 312
2019 Revenue in Millions : 384
Growth (%) : -19
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 236
2020 Revenue in Millions : 299
Growth (%) : -15
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 236
2021 Revenue in Millions : 236
Growth (%) : 0
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 182
2022 Revenue in Millions : 226
Growth (%) : -9
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 384
2016 Revenue in Millions : 372
Growth (%) : 3
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 338
2017 Revenue in Millions : 360
Growth (%) : -6%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 369
2018 Revenue in Millions : 350
Growth (%) : 6
LOOKING FOR A SUPPLIER?